FDA Funding Up Slightly In 2015 Funding BiIl, But Device Dollars Stay Flat
This article was originally published in The Gray Sheet
Executive Summary
Spending agreement would give FDA about a 1.3 percent increase from fiscal year 2014, in part due to a $25 million one-time increase targeted at the Ebola crisis, but funding for device activities would remain flat at $420.55 million.